EUVIMEDEUVIMED entdecken
Crossref

Reverse N -Substituted Hydroxamic Acid Derivatives of Fosmidomycin Target a Previously Unknown Subpocket of 1-Deoxy- d- xylulose 5-Phosphate Reductoisomerase (DXR)

Mona A Abdullaziz, Sana Takada iD, Boris Illarionov, Lais Pessanha de Carvalho, Yasumitsu Sakamoto, Stefan Höfmann iD, Talea Knak, Anna-Lene Kiffe-Delf, Flaminia Mazzone iD, Klaus Pfeffer, Rainer Kalscheuer iD, Adelbert Bacher und 4 weitere

ACS Infectious Diseases · 2024

DOI: 10.1021/acsinfecdis.4c00100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Mona A Abdullaziz und 15 weiteren Autor:innen. Beteiligte Einrichtung: Heinrich Heine University Düsseldorf, Faculty of Mathematics and Natural Sciences, Institute of Pharmaceutical and Medicinal Chemistry, Universitätss…. Hauptthemen laut MEDLINE: Fosfomycin, Aldose-Ketose Isomerases, Plasmodium falciparum, Hydroxamic Acids. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Deutscher Akademischer Austauschdienst, Deutsche Forschungsgemeinschaft, Ministry of Higher Education and Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reverse analogs of the phosphonohydroxamic acid antibiotic fosmidomycin are potent inhibitors of the nonmevalonate isoprenoid biosynthesis enzyme 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR, IspC) of Plasmodium falciparum. Some novel analogs with large phenylalkyl substituents at the hydroxamic acid nitrogen exhibit nanomolar PfDXR inhibition and potent in vitro growth inhibition of P. falciparum parasites coupled with good parasite selectivity. X-ray crystallographic studies demonstrated that the N-phenylpropyl substituent of the newly developed lead compound 13e is accommodated in a subpocket within the DXR catalytic domain but does not reach the NADPH binding pocket of the N-terminal domain. As shown for reverse carba and thia analogs, PfDXR selectively binds the S-enantiomer of the new lead compound. In addition, some representatives of the novel inhibitor subclass are nanomolar Escherichia coli DXR inhibitors, whereas the inhibition of Mycobacterium tuberculosis DXR is considerably weaker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FosfomycinAldose-Ketose IsomerasesPlasmodium falciparumHydroxamic AcidsAntimalarialsMultienzyme ComplexesCrystallography, X-RayEnzyme InhibitorsStructure-Activity RelationshipEscherichia coliModels, MolecularMycobacterium tuberculosisCatalytic DomainOxidoreductases

Stichwörter der Autor:innen

1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR, IspC)N-substituted hydroxamic acidsantiplasmodial activitycocrystal structuresfosmidomycinnonmevalonate biosynthesis pathway

Substanzen

1-deoxy-D-xylulose 5-phosphate reductoisomeraseFosfomycinAldose-Ketose IsomerasesfosmidomycinHydroxamic AcidsAntimalarialsMultienzyme ComplexesEnzyme InhibitorsOxidoreductases

Autor:innen und Institutionen

  • Heinrich Heine University Düsseldorf, Faculty of Mathematics and Natural Sciences, Institute of Pharmaceutical and Medicinal Chemistry, Universitätsstr. 1, 40225 Düsseldorf, Germany.
  • National Research Centre (NRC), 33 El Buhouth St, Ad Doqi, Dokki, Cairo 12622, Egypt.
  • School of Pharmacy, Kitasato University, Minato-ku, Tokyo 108-8641, Japan.
  • Hamburg School of Food Science, Universität Hamburg, Grindelallee 117, 20146 Hamburg, Germany.
  • Institut für Tropenmedizin, Eberhard Karls Universität Tübingen, Wilhelmstr. 27, 72074 Tübingen, Germany.
  • School of Pharmacy, Iwate Medical University, Yahaba, Iwate 028-3694, Japan.

ORCID-Profile: Sana Takada, Stefan Höfmann, Flaminia Mazzone, Rainer Kalscheuer, Nobutada Tanaka, Thomas Kurz

Förderung

  • Deutscher Akademischer Austauschdienst
  • Deutsche Forschungsgemeinschaft
  • Ministry of Higher Education and Scientific Research
  • Japan Society for the Promotion of Science
  • Heiwa Nakajima Foundation

Zitieren

APA

Abdullaziz, M. A., Takada, S., Illarionov, B., Pessanha de Carvalho, L., Sakamoto, Y., Höfmann, S., Knak, T., Kiffe-Delf, A. L., Mazzone, F., Pfeffer, K., Kalscheuer, R., Bacher, A., Held, J., Fischer, M., Tanaka, N., & Kurz, T. (2024). Reverse N -Substituted Hydroxamic Acid Derivatives of Fosmidomycin Target a Previously Unknown Subpocket of 1-Deoxy- d- xylulose 5-Phosphate Reductoisomerase (DXR). ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00100

Vancouver

Abdullaziz MA, Takada S, Illarionov B, Pessanha de Carvalho L, Sakamoto Y, Höfmann S, et al. Reverse N -Substituted Hydroxamic Acid Derivatives of Fosmidomycin Target a Previously Unknown Subpocket of 1-Deoxy- d- xylulose 5-Phosphate Reductoisomerase (DXR). ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.4c00100

BibTeX
@article{Abdullaziz2024,
  author = {Abdullaziz, Mona A and Takada, Sana and Illarionov, Boris and Pessanha de Carvalho, Lais and Sakamoto, Yasumitsu and Höfmann, Stefan and Knak, Talea and Kiffe-Delf, Anna-Lene and Mazzone, Flaminia and Pfeffer, Klaus and Kalscheuer, Rainer and Bacher, Adelbert and Held, Jana and Fischer, Markus and Tanaka, Nobutada and Kurz, Thomas},
  title = {Reverse N -Substituted Hydroxamic Acid Derivatives of Fosmidomycin Target a Previously Unknown Subpocket of 1-Deoxy- d- xylulose 5-Phosphate Reductoisomerase (DXR)},
  journal = {ACS Infectious Diseases},
  year = {2024},
  doi = {10.1021/acsinfecdis.4c00100}
}
Kostenlos starten →